Mapping of the full length and the truncated interleukin-18 receptor alpha in the mouse brain

Journal of Neuroimmunology

Volumn 214, Issue 1-2, 2009, Pages 43-54

  Alboni, Silvia ^a   Cervia, Davide ^b   Ross, Brendon ^c   Montanari, Claudia ^a   Gonzalez, Alejandro Sanchez ^c   Sanchez Alavez, Manuel ^c   Marcondes, Maria Cecilia Garibaldi ^c   De Vries, David ^c   Sugama, Shuei ^d   Brunello, Nicoletta ^a   Blom, Joan ^a   Tascedda, Fabio ^a   Conti, Bruno ^c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF TUSCIA   (Italy)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Brain; IL 18; IL 18R; Interleukin; Isoform; Receptor

Indexed keywords

INTERLEUKIN 18 RECEPTOR ALPHA; ISOPROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; BRAIN REGION; CONTROLLED STUDY; GENETIC TRANSCRIPTION; INTRACELLULAR SPACE; MOUSE; NEUROMODULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSCRIPTION REGULATION;

ALTERNATIVE SPLICING; ANIMALS; BRAIN; CEREBELLUM; CEREBRAL CORTEX; EXONS; HIPPOCAMPUS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERLEUKIN-18; INTERLEUKIN-18 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-18 RECEPTOR BETA SUBUNIT; INTRONS; MICE; MICE, INBRED C57BL; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 69949179196     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.06.016     Document Type: Article

References (52)

1. Andoh T., Kishi H., Motoki K., Nakanishi K., Kuraishi Y., and Muraguchi A. Protective effect of IL-18 on kainate- and IL-1 beta-induced cerebellar ataxia in mice. J. Immunol. 180 (2008) 2322-2328
2. Andre R., Wheeler R.D., Collins P.D., Luheshi G.N., Pickering-Brown S., Kimber I., Rothwell N.J., and Pinteaux E. Identification of a truncated IL-18R beta mRNA: a putative regulator of IL-18 expressed in rat brain. J. Neuroimmunol. 145 (2003) 40-45
3. Bossu P., Ciaramella A., Moro M.L., Bellincampi L., Bernardini S., Federici G., Trequattrini A., Macciardi F., Spoletini I., Di Iulio F., Caltagirone C., and Spalletta G. Interleukin 18 gene polymorphisms predict risk and outcome of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 78 (2007) 807-811
4. Bourke E., Cassetti A., Villa A., Fadlon E., Colotta F., and Mantovani A. IL-1 beta scavenging by the type II IL-1 decoy receptor in human neutrophils. J. Immunol. 170 (2003) 5999-6005
5. Colotta F., Re F., Muzio M., Bertini R., Polentarutti N., Sironi M., Giri J.G., Dower S.K., Sims J.E., and Mantovani A. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261 (1993) 472-475
6. Colotta F., Dower S.K., Sims J.E., and Mantovani A. The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1. Immunol. Today 15 (1994) 562-566
7. Conti B., Park L.C., Calingasan N.Y., Kim Y., Kim H., Bae Y., Gibson G.E., and Joh T.H. Cultures of astrocytes and microglia express interleukin 18. Brain Res. Mol. Brain Res. 67 (1999) 46-52
8. Cumiskey D., Pickering M., and O'Connor J.J. Interleukin-18 mediated inhibition of LTP in the rat dentate gyrus is attenuated in the presence of mGluR antagonists. Neurosci. Lett. 412 (2007) 206-210
9. Cumiskey D., Curran B.P., Herron C.E., and O'Connor J.J. A role for inflammatory mediators in the IL-18 mediated attenuation of LTP in the rat dentate gyrus. Neuropharmacology 52 (2007) 1616-1623
10. Curran B., and O'Connor J.J. The pro-inflammatory cytokine interleukin-18 impairs long-term potentiation and NMDA receptor-mediated transmission in the rat hippocampus in vitro. Neuroscience 108 (2001) 83-90
11. Davis C.N., Tabarean I., Gaidarova S., Behrens M.M., and Bartfai T. IL-1beta induces a MyD88-dependent and ceramide-mediated activation of Src in anterior hypothalamic neurons. J. Neurochem. 98 (2006) 1379-1389
12. Felderhoff-Mueser U., Schmidt O.I., Oberholzer A., Bührer C., and Stahel P.F. IL-18: a key player in neuroinflammation and neurodegeneration?. Trends Neurosci. 28 (2005) 487-493
13. Fiszer D., Rozwadowska N., Rychlewski L., Kosicki W., and Kurpisz M. Identification of IL-18RAP mRNA truncated splice variants in human testis and the other human tissues. Cytokine 39 (2007) 178-183
14. Franklin K.B.J., and Paxinos G. The mouse brain in stereotaxic cooredinates (1997), Academic Press, San Diego
15. Gatti S., Beck J., Fantuzzi G., Bartfai T., and Dinarello C.A. Effect of interleukin-18 on mouse core body temperature. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282 (2002) R702-R709
16. Hedtjarn M., Leverin A.L., Eriksson K., Blomgren K., Mallard C., and Hagberg H. Interleukin-18 involvement in hypoxic-ischemic brain injury. J. Neurosci. 22 (2002) 5910-5919
17. Jander S., Schroeter M., and Stoll G. Interleukin-18 expression after focal ischemia of the rat brain: association with the late-stage inflammatory response. J. Cereb. Blood Flow Metab. 22 (2002) 62-70
18. Jeon G.S., Park S.K., Park S.W., Kim D.W., Chung C.K., and Cho S.S. Glial expression of interleukin-18 and its receptor after excitotoxic damage in the mouse hippocampus. Neurochem. Res. 33 (2008) 179-184
19. Kanno T., Nagata T., Yamamoto S., Okamura H., and Nishizaki T. Interleukin-18 stimulates synaptically released glutamate and enhances postsynaptic AMPA receptor responses in the CA1 region of mouse hippocampal slices. Brain Res. 1012 (2004) 190-193
20. Kato Z., Jee J., Shikano H., Mishima M., Ohki I., Ohnishi H., Li A., Hashimoto K., Matsukuma E., Omoya K., Yamamoto Y., Yoneda T., Hara T., Kondo N., and Shirakawa M. The structure and binding mode of interleukin-18. Nat. Struct. Biol. 10 (2003) 966-971
21. Kokai M., Kashiwamura S., Okamura H., Ohara K., and Morita Y. Plasma interleukin-18 levels in patients with psychiatric disorders. J. Immunother. 25 Suppl 1 (2002) S68-S71
22. Kroes R.A., Panksepp J., Burgdorf J., Otto N.J., and Moskal J.R. Modeling depression: social dominance-submission gene expression patterns in rat neocortex. Neuroscience. 137 (2006) 37-49
23. Kubota T., Fang J., Brown R.A., and Krueger J.M. Interleukin-18 promotes sleep in rabbits and rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281 (2001) R828-R838
24. Lang D., Knop J., Wesche H., Raffetseder U., Kurrle R., Boraschi D., and Martin M.U. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. J. Immunol. 161 (1998) 6871-6877
25. Lu L.X., Guo S.Q., Chen W., Li Q., Cheng J., and Guo J.H. Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia. Di Yi Jun Yi Da Xue Xue Bao. 24 (2004) 1251-1254
26. Malinowsky D., Lundkvist J., Layé S., and Bartfai T. Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor. FEBS Lett. 429 (1998) 299-302
27. Mantovani A., Locati M., Vecchi A., Sozzani S., and Allavena P. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol. 22 (2001) 328-336
28. Merendino R.A., Di Rosa A.E., Di Pasquale G., Minciullo P.L., Mangraviti C., Costantino A., Ruello A., and Gangemi S. Interleukin-18 and CD30 serum levels in patients with moderate-severe depression. Mediators Inflamm. 11 (2002) 265-267
29. Mori I., Hossain M.J., Takeda K., Okamura H., Imai Y., Kohsaka S., and Kimura Y. Impaired microglial activation in the brain of IL-18-gene-disrupted mice after neurovirulent influenza A virus infection. Virology. 287 (2001) 163-170
30. Netea M.G., Joosten L.A., Lewis E., Jensen D.R., Voshol P.J., Kullberg B.J., Tack C.J., van Krieken H., Kim S.H., Stalenhoef A.F., van de Loo F.A., Verschueren I., Pulawa L., Akira S., Eckel R.H., Dinarello C.A., van den Berg W., and van der Meer J.W. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med. 12 (2006) 650-656
31. Novick D., Kim S.H., Fantuzzi G., Reznikov L.L., Dinarello C.A., and Rubinstein M. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10 (1999) 127-136
32. Ojala J., Alafuzoff I., Herukka S.K., van Groen T., Tanila H., and Pirttila T. Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients. Neurobiol. Aging 30 (2009) 198-209
33. Paolini A.G., and McKenzie J.S. Intracellular recording of magnocellular preoptic neuron responses to olfactory brain. Neuroscience 78 (1997) 229-242
34. Patterson, P.H., 2009. Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res. [Epub ahead of print]
35. Parnet P., Garka K.E., Bonnert T.P., Dower S.K., and Sims J.E. IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP. J. Biol. Chem. 271 (1996) 3967-3970
36. Prinz M., and Hanisch U.K. Murine microglial cells produce and respond to interleukin-18. J. Neurochem. 72 (1999) 2215-2218
37. Saad W.A., Luiz A.C., De Arruda Camargo L.A., Renzi A., and Manani J.V. The lateral preoptic area plays a dual role in the regulation of thirst in the rat. Brain Res. Bull. 39 (1996) 171-176
38. Sanchez-Alavez M., Tabarean I.V., Behrens M.M., and Bartfai T. Ceramide mediates the rapid phase of febrile response to IL-1beta. Proc. Natl. Acad. Sci. U S A. 103 (2006) 2904-2908
39. Schmidt M.H., Valatx J.L., Sakai K., Fort P., and Jouvet M. Role of the lateral preoptic area in sleep-related erectile mechanisms and sleep generation in the rat. J. Neurosci. 20 (2000) 6640-6647
40. Sergi B., and Penttila I. Interleukin 18 receptor. J. Biol. Regul. Homeost. Agents 18 (2004) 55-61
41. Shirts B.H., Wood J., Yolken R.H., and Nimgaonkar V.L. Comprehensive evaluation of positional candidates in the IL-18 pathway reveals suggestive associations with schizophrenia and herpes virus seropositivity. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 147 (2008) 343-350
42. Strausberg R.L., Feingold E.A., Grouse L.H., Derge J.G., Klausner R.D., Collins F.S., Wagner L., Shenmen C.M., Schuler G.D., Altschul S.F., Zeeberg B., Buetow K.H., Schaefer C.F., Bhat N.K., Hopkins R.F., Jordan H., Moore T., Max S.I., Wang J., Hsieh F., Diatchenko L., Marusina K., Farmer A.A., Rubin G.M., Hong L., Stapleton M., Soares M.B., Bonaldo M.F., Casavant T.L., Scheetz T.E., Brownstein M.J., Usdin T.B., Toshiyuki S., Carninci P., Prange C., Raha S.S., Loquellano N.A., Peters G.J., Abramson R.D., Mullahy S.J., Bosak S.A., McEwan P.J., McKernan K.J., Malek J.A., Gunaratne P.H., Richards S., Worley K.C., Hale S., Garcia A.M., Gay L.J., Hulyk S.W., Villalon D.K., Muzny D.M., Sodergren E.J., Lu X., Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S., Sanchez A., Whiting M., Madan A., Young A.C., Shevchenko Y., Bouffard G.G., Blakesley R.W., Touchman J.W., Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J., Myers R.M., Butterfield Y.S., Krzywinski M.I., Skalska U., Smailus D.E., Schnerch A., Schein J.E., Jones S.J., Marra M.A., and Team M. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc. Natl. Acad. Sci. U S A 99 (2002) 16899-16903
43. Sugama S., and Conti B. Interleukin-18 and stress. Brain Res Rev. 58 (2008) 85-95
44. Sugama S., Cho B.P., Baker H., Joh T.H., Lucero J., and Conti B. Neurons of the superior nucleus of the medial habenula and ependymal cells express IL-18 in rat CNS. Brain Res. 958 (2002) 1-9
45. Sugama S., Wirz S.A., Barr A.M., Conti B., Bartfai T., and Shibasaki T. Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine treatment. Neuroscience 128 (2004) 451-458
46. Sugama S., Fujita M., Hashimoto M., and Conti B. Stress induced morphological microglial activation in the rodent brain: involvement of interleukin-18. Neuroscience 146 (2007) 1388-1399
47. Tanaka K.F., Shintani F., Fujii Y., Yagi G., and Asai M. Serum interleukin-18 levels are elevated in schizophrenia. Psychiatry Res. 96 (2000) 75-80
48. Torigoe K., Ushio S., Okura T., Kobayashi S., Taniai M., Kunikata T., Murakami T., Sanou O., Kojima H., Fujii M., Ohta T., Ikeda M., Ikegami H., and Kurimoto M. Purification and characterization of the human interleukin-18 receptor. J. Biol. Chem. 272 (1997) 25737-25742
49. Viviani B., Bartesaghi S., Gardoni F., Vezzani A., Behrens M.M., Bartfai T., Binaglia M., Corsini E., Di Luca M., Galli C.L., and Marinovich M. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci. 23 (2003) 8692-8700
50. Wang J., and Swann J.M. The magnocellular medial preoptic nucleus I. Sources of afferent input. Neuroscience 141 (2006) 1437-1456
51. Wheeler R.D., Boutin H., Touzani O., Luheshi G.N., Takeda K., and Rothwell N.J. No role for interleukin-18 in acute murine stroke-induced brain injury. J. Cereb. Blood Flow Metab. 23 (2003) 531-535
52. Zorrilla E.P., Sanchez-Alavez M., Sugama S., Brennan M., Fernandez R., Bartfai T., and Conti B. Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency. Proc. Natl. Acad. Sci. U S A 104 (2007) 11097-11102